Advertisement
Screener

PROCEPT BioRobotics Corporation (PRCT) Graph

PRCT Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $94.50M; Cost of revenue $32.12M; Research and development $20.10M; Selling, general and administrative $69.67M.
  • 2026-03-31: Revenue $83.13M; Cost of revenue $29.18M; Research and development $21.46M; Selling, general and administrative $65.09M.
  • 2025-12-31: Revenue $76.38M*; Cost of revenue $30.07M*; Research and development $19.06M*; Selling, general and administrative $58.30M*.
  • 2025-09-30: Revenue $83.33M; Cost of revenue $29.32M; Research and development $18.19M; Selling, general and administrative $59.01M.

Geography

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

PRCT revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Non Us$11.08MUS$83.42MRevenue$94.50MCost of revenue$32.12MGross profit$62.38MOperating expenses$89.77MOperating income-$27.39MResearch & development$20.10MSelling, general& administrative$69.67MPre-tax income-$26.77MIncome tax$94.00KNet income-$26.86M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$94.50M$32.12M$20.10M$69.67M$89.77M$94.00K-$26.86M
2026-03-31$83.13M$29.18M$21.46M$65.09M$86.55M-$43.00K-$31.64M
2025-12-31$76.38M*$30.07M*$19.06M*$58.30M*$77.35M*(m)$65.63M*
2025-09-30$83.33M$29.32M$18.19M$59.01M$77.20M(m)-$21.41M
2025-06-30$79.18M$27.44M$17.63M$56.30M$73.94M$136.00K-$19.58M
2025-03-31$69.16M$25.00M$16.40M$55.20M$71.60M-$47.00K-$24.74M
2024-09-30$58.37M$21.46M$16.65M$42.69M$59.34M(m)-$20.97M
2024-06-30$53.35M$21.87M$17.50M$40.81M$58.31M(m)-$25.63M
2024-03-31$44.54M$19.50M$13.08M$39.60M$52.68M(m)-$25.96M
2023-09-30$35.10M$16.23M$11.60M$32.88M$44.48M(m)-$24.62M
2023-06-30$33.10M$14.68M$11.61M$32.44M$44.05M(m)-$25.29M
2023-03-31$24.40M$11.91M$10.74M$30.13M$40.87M(m)-$28.48M
2022-09-30$20.35M$10.12M$7.58M$24.75M$32.34M(m)-$22.61M
2022-06-30$16.69M$8.21M$6.71M$19.66M$26.36M(m)-$19.18M
2022-03-31$14.20M$6.50M$5.01M$18.39M$23.40M(m)-$17.18M
2021-09-30$8.67M$4.43M$4.92M$12.12M$17.04M(m)-$14.10M
2021-06-30$8.48M$4.89M$4.48M$12.30M$16.77M(m)-$14.58M
2021-03-31$7.19M$3.67M$4.52M$10.35M$14.87M(m)-$12.82M
2020-09-30$2.11M$2.14M$3.89M$7.05M$10.95M(m)-$12.01M
2020-06-30(m)(m)(m)(m)(m)(m)-$12.61M
2020-03-31(m)(m)(m)(m)(m)(m)-$13.13M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$177.63M$61.30M$41.57M$134.76M$176.32M$51.00K-$58.50M
2025-06-30$148.34M$52.44M$34.03M$111.50M$145.53M$89.00K-$44.32M
2024-06-30$97.89M$41.38M$30.59M$80.41M$110.99M(m)-$51.58M
2023-06-30$57.51M$26.59M$22.35M$62.57M$84.92M(m)-$53.77M
2022-06-30$30.89M$14.71M$11.72M$38.04M$49.76M(m)-$36.37M
2021-06-30$15.67M$8.56M$9.00M$22.65M$31.65M(m)-$27.40M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesNet income
2025-09-30$231.67M$81.76M$52.22M$170.51M$222.73M-$65.73M
2024-09-30$156.26M$62.84M$47.23M$123.10M$170.33M-$72.56M
2023-09-30$92.61M$42.82M$33.95M$95.46M$129.41M-$78.39M
2022-09-30$51.24M$24.83M$19.30M$62.79M$82.09M-$58.98M
2021-09-30$24.34M$12.99M$13.92M$34.77M$48.68M-$41.51M
2020-09-30$4.50M$6.22M$11.73M$21.14M$32.87M-$37.74M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-12-31$308.05M$111.83M$71.28M$228.81M$300.08M$190.00K-$95.57K
2024-12-31$224.50M$87.40M$62.30M$171.41M$233.71M$368.00K-$91.41K
2023-12-31$136.19M$65.14M$48.45M$131.77M$180.22M$80.00K-$105.90K
2022-12-31$75.01M$37.93M$28.98M$88.83M$117.81M$0.00-$87.15K
2021-12-31$34.47M$18.61M$18.99M$51.04M$70.03M$0.00-$59.85K
2020-12-31$7.72M$8.97M$16.27M$30.27M$46.55M$0.00-$53.02M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
SpyGlass Pharma, Inc. (SGP)United States$0.925B
IRADIMED CORP (IRMD)United States$1.089B52.92
ARTIVION, INC. (AORT)United States$1.123B-345.09
SI-BONE, Inc. (SIBN)United States$0.830B-49.82
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
ANGIODYNAMICS INC (ANGO)United States$0.632B-13.02
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B